Indian Rheumatoid Arthritis Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1392

  • Format: PPT, PDF

Indian Rheumatoid Arthritis Drugs Market: Segmented By Drugs Class (Biologic Agents, Corticosteroids, Disease Modifying Antirheumatic Drugs (DMARDs), Nonsteroidal Anti-Inflammatory Drug, Others), By Route of Administration (Oral & Parenteral), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) – Growth, Trends, and Forecast (2019 – 2028)

Clear
SKU: 1392 Categories: ,

Report Overview

Indian Rheumatoid Arthritis Drugs market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Rheumatoid arthritis is an inflammatory disease that results to cause pain and swelling in and around the joints. It usually affects hands and feet but can also affect any joint in the body.  Rheumatoid arthritis is an autoimmune condition because of the immune cells targeting healthy body tissues. Patients can have joint swelling, stiffness and pain due to destruction of cartilage tissues and bones. The exact cause of disease is still unknown. Rheumatoid arthritis has four stages of progression and stage 3 shows the severe form of the disease. Rheumatoid arthritis affects performance of daily activities, like household tasks and work, and also results in mortality.

Market Drivers

The rising prevalence of rheumatoid arthritis in India, introduction of new therapeutic agents and government support on high cost treatment products are some of the major factors driving the rheumatoid arthritis market. These therapeutic treatment stops inflammation, relieve symptoms, prevent joint and organ damages and decreases long term complications which attracts rheumatoid arthritis patients to opt for these treatments, which results in market growth. Rising government initiatives to give quality and affordable healthcare are anticipated to supplement development of India’s market. In addition, India is considered as one of the top countries of infections in the world, increasing the requirement for rheumatoid arthritis treatment around the country. Rising patient pool because of increase in population, lifestyle changes, and emergence of new diseases is also driving interest in biopharmaceuticals.

1. Indian Rheumatoid Arthritis Drugs Market Overview……………………………
A. Market Size
2. Market Growth Drivers………………………………………….……………………….
A. Rising Prevalence of Rheumatoid Arthritis in India
B. Introduction of New Therapeutic Agents
C. Government Support on High Cost Treatment Products
D. Increasing Product Launches and Products Under Pipelines
3. Epidemiological Prevalence……………………………………………………………
A. Age-Specific
B. Incidence Rate
C. Gender-Specific
4. Rheumatoid Arthritis Drugs Market Segmentation……………………………..
A. Drug class
I. Biologic Agents
II. Corticosteroids
III. Disease Modifying Antirheumatic Drugs (DMARDs)
IV. Nonsteroidal Anti-Inflammatory Drug
V. Others
B. Route of Administration
I. Oral
II. Parenteral
C. Distribution types
I. Hospital Pharmacy
II. Retail Pharmacy
III. Online Pharmacy
5. Rheumatoid Arthritis Drugs Major Products Market Share…………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Sanofi S.A Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Rheumatoid Arthritis Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on drug class, the rheumatoid arthritis drugs market is segmented into biologic agents, corticosteroids, disease modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drug, others. Disease modifying antirheumatic drugs accounted for significant revenue share in 2018. Hydroxychloroquine, methotrexate, leflunomide and sulfasalazine are some of the commonly used traditional DMARDs.

By Route of Administration:

Based on route of administration, rheumatoid arthritis drugs market is segmented into oral and parenteral segments. Parenteral segment is projected to witness robust growth over the analysis timeframe. Bioavailability of drugs are significantly higher in parenteral form compared to oral dosage form. For instance, parenteral methotrexate was found to be more effective and indicated no additional adverse effects compared to oral methotrexate.

By Distribution channels:

Based on distribution channels, rheumatoid arthritis drugs market is segmented into hospitals, retail pharmacies and online platforms. Online platforms will witness lucrative growth over the forecast timeframe due to increasing internet penetration and growing digital literacy rates in developing regions. Moreover, ease of usage and heavy discounts offered by online sellers on antirheumatic drugs will augment the segment growth.

Major Players

The major players for Rheumatoid Arthritis treatment in Indian includes Sanofi S.A., Pfizer Inc., Johnson & Johnson, AbbVie Inc., Eli Lilly & Company, Cipla, Inc., Sun Pharmaceutical Industries Ltd., Novartis AG.  For instance, in 2020, Pfizer and Lilly went into a collaboration agreement to jointly develop and globally commercialize tanezumab for the treatment of osteoarthritis pain and cancer pain, under which the companies equally share ongoing development costs.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements